Jack Anders, Chief Financial Officer at Revolution Medicines, Inc. (RVMD), sold 2,722 shares at $156.12 ($425K) on 2026-06-16, disclosed to the SEC on 2026-06-18.
Scheduled sale ($425k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RVMD | SELL | 2026-03-19 | $548K | — | Filing → |
| RVMD | SELL | 2026-01-09 | $980K | — | Filing → |
| RVMD | SELL | 2025-12-18 | $479K | — | Filing → |